CAS No. 22457 -89-2 Cure Beriberi Benfotiamine Powder

China CAS No. 22457-89-2 Cure Beriberi Benfotiamine Powder, Find details about China Benfotiamine, Benfotiamine Powder from CAS No. 22457-89-2 Cure Beriberi Benfotiamine Powder

MW
466.45
Appearance
White Powder
Melting Point
200ºC
Transport Package
Bag or Drum
Specification
99%
Origin
China
MW
466.45
Appearance
White Powder
Melting Point
200ºC
Transport Package
Bag or Drum
Specification
99%
Origin
China

Product Description
 
Product Name
Benfotiamine
CAS NO.
22457-89-2
MF NO.
C19H23N4O6PS
Moisture content
≤1.0%
Apperance
White   powder
Purity
99%
Melting point
200ºC

CAS No. 22457-89-2 Cure Beriberi Benfotiamine Powder
Benfotiamine Powder is a fat-soluble vitamin B1 derivative. In addition to the physical and chemical properties that are different from water-soluble vitamin B1, the difference in structure is that there is an open thiazole ring, which is formed with physiological activity through ring closure in the body Vitamin B1.
After taking Benfotiamine  the maximum blood concentration of vitamin B1 is about 5 times higher than that of vitamin B1, and the maximum bioavailability of benfotiamine is about 3.6 times that of vitamin B1, and Benfotiamine  is higher than other fat-soluble vitamin B1 derivatives . Human and animal studies have proved that benfotiamine has higher bioavailability and biological activity compared to the water-soluble vitamin form. Compared with vitamin B1, in plasma, whole blood, red blood cells and tissues, benfotiamine produces a higher peak and total concentration of vitamin B1 and its phosphate, and its plasma half-life is also longer. The relative bioavailability of benfotiamine  increases more significantly in muscle tissue (5 times) and brain (25 times), and 10-40% in other tissues such as liver and kidney.


Function

(1) For the prevention and treatment of vitamin B1 deficiency;
(2) It is used for supplement when the demand of vitamin B1 is increased and insufficient intake from food (fatigue,
hyperthyroidism, pregnancy, lactation, severe physical labor, etc.);
(3) For the treatment of non alcoholic Wernicke encephalopathy;
(4) For the treatment of beriberi;
(5) It can be used in the 
following diseases to speculate the treatment related to vitamin B1 deficiency and metabolic disorders, such as neuralgia, muscle pain, joint pain, peripheral neuritis, peripheral nerve paralysis, myocardial metabolic disorder, constipation and other gastrointestinal motor dysfunction.

CAS No. 22457-89-2 Cure Beriberi Benfotiamine PowderCAS No. 22457-89-2 Cure Beriberi Benfotiamine PowderCAS No. 22457-89-2 Cure Beriberi Benfotiamine PowderCAS No. 22457-89-2 Cure Beriberi Benfotiamine PowderCAS No. 22457-89-2 Cure Beriberi Benfotiamine PowderCAS No. 22457-89-2 Cure Beriberi Benfotiamine Powder